AR019532A1 - PHARMACEUTICAL COMPOSITION OF THE COMPOSITE 1,5-DIDEOXI-1,5-IMIN-D-GLUCITOL N-REPLACED - Google Patents

PHARMACEUTICAL COMPOSITION OF THE COMPOSITE 1,5-DIDEOXI-1,5-IMIN-D-GLUCITOL N-REPLACED

Info

Publication number
AR019532A1
AR019532A1 ARP990100609A AR019532A1 AR 019532 A1 AR019532 A1 AR 019532A1 AR P990100609 A ARP990100609 A AR P990100609A AR 019532 A1 AR019532 A1 AR 019532A1
Authority
AR
Argentina
Prior art keywords
imin
glucitol
agents
dideoxi
composite
Prior art date
Application number
Other languages
Spanish (es)
Original Assignee
Searle Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Searle Llc filed Critical Searle Llc
Publication of AR019532A1 publication Critical patent/AR019532A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Se proveen métodos y composiciones para el tratamiento de infecciones por virus de hepatitis en mamíferos, en especial seres humanos. Los métodoscomprenden: (1) la administracion de compuestos 1,5-dideoxi-1,5-imin-D-glucitol N-sustituido solos o en combinacion con agentes antivirales nucleosídicos,agentes antivirales nucleotídicos, mezclas de los mismos o agentes inmunomoduladores/inmunoestimuladores, o bien (2) la administracion de compuestos1,5-dideoxi-1,5-imin-D-glucitol N-sustituido solo o en combinacion con agentes antiviales nucleosídicos, agentes antivirales nucleotídicos, o mezclas de losmismos, y agentes inmunomoduladores/inmunoestimuladores.Methods and compositions are provided for the treatment of hepatitis virus infections in mammals, especially humans. The methods comprise: (1) the administration of N-substituted 1,5-dideoxy-1,5-imin-D-glucitol compounds alone or in combination with nucleoside antiviral agents, nucleotide antiviral agents, mixtures thereof or immunomodulatory / immunostimulatory agents , or (2) the administration of N-substituted 1,5-dideoxy-1,5-imin-D-glucitol compounds alone or in combination with nucleoside antivial agents, nucleotide antiviral agents, or mixtures thereof, and immunomodulatory / immunostimulatory agents .

ARP990100609 1998-02-12 1999-02-12 PHARMACEUTICAL COMPOSITION OF THE COMPOSITE 1,5-DIDEOXI-1,5-IMIN-D-GLUCITOL N-REPLACED AR019532A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7450898P 1998-02-12 1998-02-12

Publications (1)

Publication Number Publication Date
AR019532A1 true AR019532A1 (en) 2002-02-27

Family

ID=22119935

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP990100609 AR019532A1 (en) 1998-02-12 1999-02-12 PHARMACEUTICAL COMPOSITION OF THE COMPOSITE 1,5-DIDEOXI-1,5-IMIN-D-GLUCITOL N-REPLACED

Country Status (3)

Country Link
CN (2) CN1202824C (en)
AR (1) AR019532A1 (en)
ZA (1) ZA991142B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101011389B (en) * 2003-09-19 2012-09-19 石药集团中奇制药技术（石家庄）有限公司 Application of arbidol in preparing medicaments for preventing and/or treating hepatitis B

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0350012A3 (en) * 1988-07-08 1990-09-05 Meiji Seika Kaisha Ltd. Antiviral composition
US5003072A (en) * 1988-11-03 1991-03-26 G. D. Searle & Co. 1,5-dideoxy-1,5-imino-D-glucitol derivatives
DE4009561A1 (en) * 1990-03-24 1991-09-26 Bayer Ag New anti-retroviral desoxy:nojirimycin derivs.
AU1876095A (en) * 1994-02-25 1995-09-11 G.D. Searle & Co. Use of 1-deoxynojirimycin and its derivatives for treating mammals infected with respiratory syncytial virus

Also Published As

Publication number Publication date
ZA991142B (en) 2000-02-14
CN1679568A (en) 2005-10-12
CN100364534C (en) 2008-01-30
CN1328457A (en) 2001-12-26
CN1202824C (en) 2005-05-25

Similar Documents

Publication Publication Date Title
BR9907882A (en) Use of unsubstituted 1,5-dideoxy-1,5-imino-d-glucitol compounds for the treatment of hepatitis virus infections
ES2150496T3 (en) CONDENSED CYCLLOALKYLIMIDAZOPYRIDIDS.
NO20100302L (en) Compositions containing organic compounds
EA200100298A1 (en) PHARMACEUTICAL PREPARATIONS WITH ADJUSTABLE LIBERATION CONTAINING THE INHIBITOR OF cGMP-PHOSPHODYSTRASE-5
CL2010000828A1 (en) Pharmaceutical composition comprising a pegylated conjugate of interferon alfa and ribavirin, useful in the preparation of a medicament for chronic hepatitis C infections.
BR0013771A (en) Compound, methods of treating a viral infection in a mammal, inhibiting hiv reverse transcriptase, and preventing hiv infection or treating hiv infection, use of a compound, and, pharmaceutical composition
CO4940414A1 (en) THERAPY OF MODIFIED POLYETHYLENE GLYCOL INTERFERONS
ES2138969T3 (en) COMBINATION OF ANTIVIRAL NUCLEOSIDES.
BR9811121A (en) Product, pharmaceutical composition, and use of a product
EA199901031A1 (en) Derivatives of benzimidazole
TR200002355T2 (en) 2- (Purin-9-yl) tetrahydrofuran-3,4-diol derivatives
CY1115417T1 (en) MODIFIED 2 'AND 3'-NUCLEOZITIC PRODUCTS FOR FLAVIVIRIDAE INFECTION TREATMENT
DE60104206D1 (en) SEMI-SOLID PREPARATION CONTAINING ISOTRETINOIN
AR021876A1 (en) COMBINATION THERAPY FOR HCV INDUCTION OF RIBAVIRINA - INTERFERON ALFA PEGILADO
MX2007004783A (en) Inhibitors of hepatitis c virus protease, and compositions and treatments using the same.
CA2362914A1 (en) Use of substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds for treating hepatitis virus infections
YU60900A (en) Novel crystalline forms of an antiviral benzimidazole compound
BR0207961A (en) Combination of epothilone analogs and chemotherapeutic agents for the treatment of proliferative diseases.
ES2083668T5 (en) ANTIVIRICAL COMBINATIONS CONTAINING NUCLEOSIDE ANALOGS.
AU6169298A (en) Use of (n)-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combinationtherapy for treating hepatitis virus infections
BR9809951A (en) Method for treating obesity
ATE100098T1 (en) NUCLEOSIDES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS.
ATE265535T1 (en) PHARMACEUTICAL COMPOSITION AGAINST TUMORS AND INFECTIONS CAUSED BY PAPILLOMA VIRUSES
James Curcumin: clinical trial finds no antiviral effect
AR019532A1 (en) PHARMACEUTICAL COMPOSITION OF THE COMPOSITE 1,5-DIDEOXI-1,5-IMIN-D-GLUCITOL N-REPLACED

Legal Events

Date Code Title Description
FB Suspension of granting procedure